Estimates Revisions Northwest Biotherapeutics, Inc.

Stocks

Market Closed - OTC Markets 03:59:59 19/09/2026 HKT			5-day change	1st Jan Change
0.1601 ^USD	-3.26%		-3.12%	-30.01%

08-15	Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-07	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. Revenue rev.	1y. EPS revision
NORTHWEST BIOTHERAPEUTICS, INC.	-	-
WUXI APPTEC CO., LTD.
ARGENX SE
INSMED INCORPORATED
BIONTECH SE
GENMAB A/S
PHARMAESSENTIA CORPORATION
EXELIXIS, INC.
SUMMIT THERAPEUTICS INC.
MADRIGAL PHARMACEUTICALS, INC.
Average
Weighted average by Cap.